3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
2
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
457
Pancreatic Neoplasms
364
Stomach Neoplasms
246
Carcinoma, Hepatocellular
231
Carcinoma, Non-Small-Cell Lung
165
Colonic Neoplasms
146
Esophageal Neoplasms
133
Neoplasms
115
Neoplasm Metastasis
115
Ovarian Neoplasms
111
Rectal Neoplasms
107
Liver Neoplasms
101
Breast Neoplasms
99
Lung Neoplasms
79
Melanoma
76
Squamous Cell Carcinoma of Head and Neck
70
Gastrointestinal Neoplasms
58
Endometrial Neoplasms
58
Carcinoma, Renal Cell
54
Uterine Cervical Neoplasms
52
Cholangiocarcinoma
52
Biliary Tract Neoplasms
52
Triple Negative Breast Neoplasms
49
Head and Neck Neoplasms
48
Sarcoma
46
Prostatic Neoplasms
45
Esophageal Squamous Cell Carcinoma
39
Urinary Bladder Neoplasms
34
Small Cell Lung Carcinoma
31
Carcinoma
29
Interventions
Sodium Chloride
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Febrile Neutropenia
×
Gastrointestinal
×
Clear all
NCT01619423
2018-07-06
PLIANT
Egetis Therapeutics
Phase 1/2
Completed
186 enrolled
12 charts